CorMedix Enlists World-Class Panel to Advise On Cardiorenal Medicine
SUMMIT, N.J., Jan. 8, 2008 (PRIME NEWSWIRE) -- CorMedix Inc., a biopharmaceutical company, today announced that it had established an advisory panel of world-renowned physicians with special expertise in cardiorenal disease -- the epidemic intersection of cardiovascular disease and renal (chronic kidney) disease